<?xml version="1.0" encoding="UTF-8"?>
<p id="para0019">Mechanistically, T-705 is incorporated into newly synthesized RNA by the viral polymerase in place of purines but not pyrimidines,
 <xref rid="bib0095" ref-type="bibr">
  <sup>95</sup>
 </xref> resulting in increased frequencies of C-to-U and G-to-A transition mutations as demonstrated for influenza viruses and hepatitis C virus both in vitro and in vivo.
 <xref rid="bib0096" ref-type="bibr">96</xref>, 
 <xref rid="bib0097" ref-type="bibr">97</xref>, 
 <xref rid="bib0098" ref-type="bibr">98</xref> Collapse of virus replication is considered to be a consequence of error catastrophe or lethal mutagenesis, resulting from the accumulation of random low-frequency mutations in the viral genome (
 <xref rid="fig0002" ref-type="fig">Fig 2</xref> ). The genetic barrier of T-705 against resistance is favorably high,
 <xref rid="bib0099" ref-type="bibr">
  <sup>99</sup>
 </xref> although a recent study has identified a pair of point mutations in the PB1 (K229R) and PA (P659L) polymerase subunits that reduce viral sensitivity to the compound by approximately 30-fold in cell culture.
 <xref rid="bib0100" ref-type="bibr">
  <sup>100</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib0101" ref-type="bibr">
  <sup>101</sup>
 </xref>
</p>
